A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

NCT07265206 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Juventas Cell Therapy Ltd.

Collaborators